In 2022, Michael Cola earned $945.42K in total compensation at Avalo Therapeutics, including $62.50K salary and $17.26K bonus. Led Avalo Therapeutics as CEO for 2 years.
Compensation History
Annual executive compensation data for Michael Cola, including salary, bonuses, and stock awards.
Year
2022
Total Compensation
$945.42K
Salary
$62.50K
Bonus
$17.26K
Other
$865.66K
Salary
$62.50KBoard Justification
The compensation philosophy aims to align executive compensation with company performance, peer benchmarking, and retention strategies, ensuring that compensation reflects individual and company performance metrics.
Bonus
$17.26KBoard Justification
Annual bonus earned based on the achievement of the Company’s goals, prorated to reflect the days worked in 2022, payable when such annual bonuses are paid to the Company’s existing personnel.
Other Compensation
$865.66KBoard Justification
Severance earned, including continued payment of base salary for 18 consecutive months, unused accrued vacation, and COBRA paid to Mr. Cola pursuant to his separation agreement.
Restricted Stock
Board Justification
No stock grants vested in 2022 as Mr. Cola's employment ended on February 14, 2022.
Performance Metrics
The performance metrics for determining the compensation include the achievement of the Company’s goals as recommended by the Compensation Committee.
Michael Cola
Ex-CEO of Avalo Therapeutics
Sector of Economy
Healthcare
CEO of Avalo Therapeutics for
2 years 0 months (Feb 2020 - Feb 2022)
Previous Experience
Unknown
Other Avalo Therapeutics CEOs
Holdings
Track Michael Cola's stock holdings and portfolio value over time.
Insider Trading
Michael Cola's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Michael Cola with competitor CEOs and industry peers.